Main caricature of Kristen Fortney, who is speaking at HLTH and is CEO at BIOAGE Overlay caricature of Kristen Fortney, who is speaking at HLTH and is CEO at BIOAGE

Kristen Fortney

CEO

BIOAGE

Kristen leads BIOAGE in its mission to develop a broad pipeline of therapies that target aging in order to increase healthspan and address chronic diseases. Kristen draws from a deep background in aging research and systems biology to develop BIOAGE’s data-driven approach to identify and target the molecular pathways that drive aging. Kristen received her PhD in Medical Biophysics from the University of Toronto, followed by postdoctoral training at Stanford University where she was a fellow of the Ellison Medical Foundation / American Federation for Aging Research. She has over 10 years of experience developing novel bioinformatics approaches for data-driven investigation into the mechanisms of aging and age-related disease, with 18 published papers spanning computational drug discovery, biomarkers of aging, and the genetics of exceptional human longevity.

See All Speakers

Some additional speakers you may like

Assistant to the President and Director of the Domestic Policy Council
The White House
Acting Chairman of the Council of Economic Advisers
The White House
Administrator
Centers for Medicare & Medicaid Services
Deputy Secretary
Health & Human Services